Search
Ondansetron
go.drugbank.com/drugs/DB00904ApprovedInvestigationalWithdrawn[L5221] The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation. … Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy.
Products: MYLAN ONDANSETRON CONCENTRATE FOR SOLUTION FOR INFUSION OR INJECTION 2MG/ML, Ondansetron Accord 2 mg/ml Injektions- oder InfusionslösungColloidal oatmeal
go.drugbank.com/drugs/DB11286ApprovedNutraceuticalPhenols are also contained in colloidal oatmeal, which possess antioxidant and anti-inflammatory activities, as well as UV-absorbing activity. … Colloidal oatmeal is a FDA-approved skin protectant that temporarily protects and helps relieve minor skin irritation and itching due to rashes, eczema, poison ivy, oak, sumac, or insect bites.
Products: End-itch for Eczema, End-itch for SunburnTrimebutine
go.drugbank.com/drugs/DB09089ApprovedInvestigationalIt is used to restore normal bowel function and is commonly present in pharmaceutical mixtures as trimebutine maleate salt form. … It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders [A19691].
Categories: Drugs for Functional Gastrointestinal DisordersInternational brands: Puridat FortPertuzumab
go.drugbank.com/drugs/DB06366ApprovedInvestigationalIt was first approved by the FDA in 2012 for use with [docetaxel] and another HER2-targeted monoclonal antibody, [trastuzumab], in the treatment of metastatic HER2-positive breast cancer.
Products: Perjeta 420 mg concentrate for solution for infusion, PERJETA CONCENTRATE FOR SOLUTION FOR INFUSION 420MG/14MLArtesunate
go.drugbank.com/drugs/DB09274ApprovedInvestigationalArtesunate is indicated for the initial treatment of severe malaria.[L14099] The World Health Organization recommends artesunate as first line treatment for severe malaria. … [L890] Artesunate was developed out of a need for a more hydrophilic derivative of [artemisinin].[A203948] Artesunate was granted FDA approval on 26 May 2020.[L14099]
Products: ARTESUNATE FOR INJECTION, ARTESUN POWDER FOR INJECTION 60 MGLevothyroxine
go.drugbank.com/drugs/DB00451ApprovedInvestigational[A179938] Prior to the development of levothyroxine, [DB09100] or desiccated thyroid, used to be the mainstay of treatment for hypothyroidism. … Levothyroxine is a synthetically produced form of thyroxine, a major endogenous hormone secreted by the thyroid gland.
Products: Levothyroxine Sodium for Injection, LEVOTHYROXINE SODIUM FOR INJECTION 500 mcg/vialHigh Risk for Breast Cancer
go.drugbank.com/conditions/DBCOND0043696Synonyms: High Risk for Breast Cancer, High Risk for Developing Breast CancerNot a candidate for surgery
go.drugbank.com/conditions/DBCOND0144299Synonyms: Not a candidate for surgeryNon candidates for trimethoprim-sulfamethoxazole
go.drugbank.com/conditions/DBCOND0127451Drugs: TrimetrexateSynonyms: Non candidates for trimethoprim-sulfamethoxazoleVirologically suppressed for 6 months
go.drugbank.com/conditions/DBCOND0119792Drugs: Tenofovir alafenamideSynonyms: Virologically suppressed for 6 months